David Whang is a Cardiology physician affiliated with Center for Brooklyn History. OpenAlex indexes 13 publications with 944 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4760 E Galbraith Rd
Suite 205
Cincinnati, OH 452366703
Telephone
513-985-0741Registry record last updated 27 Jul 2011.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Baxter HealthcareProgram year20251 payment
- Boston Scientific CorporationProgram year20231 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.6%Beta blocker24.1%Metoprolol Tartrate43%Metoprolol Succinate39%Carvedilol18%Part D≥42 patientsStatin14.5%Atorvastatin Calcium60%Simvastatin21%Rosuvastatin Calcium19%Part D<11 patients+ 10 more classes in this area
Blood & clotting
22.3%Factor Xa inhibitor12.9%Eliquis75%Xarelto25%Part D<11 patientsP2Y12 inhibitor5.2%Clopidogrel100%Part D≥20 patients+ 1 more class in this area
Metabolism & gastrointestinal
2.1%Potassium supplement2.1%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- ALTERNATING RIGHT AND LEFT HEART BLOCK IN LYME CARDITIS, A CASE REPORT
Journal of the American College of Cardiology
2025 - Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management
Catheterization and Cardiovascular Interventions
2001 - Abciximab provides cost-effective survival advantage in high-volume interventional practice
American Heart Journal
2000
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”